Outcomes to the Nutritional Need of Patients With Parkinson's Disease
Trial
N/A
Unknown
Sept. 27, 2021
Preliminary Study of the Quality of the Oral Flora in Parkinson's Patients
Trial
N/A
Completed
Sept. 27, 2021
The Sensitivity and Specificity of Canine Detection of Parkinson's Disease
Trial
N/A
Completed
Sept. 26, 2021
Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects
Trial
Phase 1
Unknown
Sept. 22, 2021
Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia
Trial
N/A
Completed
Sept. 22, 2021
Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease
Trial
N/A
Withdrawn
Sept. 20, 2021
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
Trial
N/A
Terminated
Sept. 20, 2021
Deep Brain Stimulation (DBS) Data Base Study
Trial
N/A
Unknown
Sept. 15, 2021
Telerehabilitation for Parkinson's Disease
Trial
N/A
Completed
Sept. 15, 2021
Effects of Exer Gaming on Balance and Gait in Parkinson's Patients
Trial
N/A
Completed
Sept. 13, 2021
Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients
Trial
N/A
Completed
Sept. 13, 2021
Fox BioNet Project: ECV-003
Trial
N/A
Completed
Sept. 7, 2021
Fox BioNet Project: LRRK2-002
Trial
N/A
Completed
Sept. 7, 2021
Challenges Faced By Neurophysiotherapist While Consultation Through Tele-rehabilitation
Trial
N/A
Completed
Sept. 7, 2021
Evaluation of an Acceptance and Commitment Therapy Group for Adjustment Difficulties in Neurological Conditions
Trial
N/A
Completed
Sept. 4, 2021
Auditory and Vestibular Function in Parkinson's Disease
Trial
N/A
Unknown
Sept. 4, 2021
Clinical Response of Impulsivity After Brain Stimulation in Parkinson's Disease
Trial
N/A
Unknown
Sept. 4, 2021
Development and Application of Tele-Neuro Rehabilitation System
Trial
N/A
Unknown
Aug. 31, 2021
A 2-Part Trial of CVL-751 in Subjects With Parkinson's Disease
Trial
Phase 1
Completed
Aug. 30, 2021
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Trial
Phase 4
Completed
Aug. 30, 2021